Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
FR 17027, a new orally absorbed cephalosporin ester, inhibited group A and B streptococci and Streptococcus pneumoniae at less than or equal to 0.1 micrograms/ml, which is similar to the inhibition concentration of amoxicillin and cefaclor, and was more active than cephalexin. It was less active (MI...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1984
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284114/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6333207/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.2.174 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|